Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Raiola

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|November 5, 2025
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMTVanderson Rocha, Myriam Labopin, Anna Maria Raiola, et al.
Bone Marrow Transplantation|May 13, 2022
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMTIvetta Danylesko, Christophe Peczynski, Myriam Labopin, et al.
Haematologica|July 5, 2006
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantationAlessandra Larocca, Giovanna Piaggio, Marina Podestà, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)Corrado Girmenia, Giovanni Barosi, Alfonso Piciocchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2018
Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission TomographyCarlo Marani, Anna Maria Raiola, Silvia Morbelli, et al.
Bone Marrow Transplantation|July 3, 2024
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)Gesine Bug, Myriam Labopin, Alexander Kulagin, et al.
American Journal of Hematology|March 4, 2026
Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical ImplicationsAnna Maria Raiola, Paola Contini, Massimiliano Gambella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised PatientsMalgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, et al.
Haematologica|October 4, 2017
Steroid treatment of acute graft-<i>versus</i>-host disease grade I: a randomized trialAndrea Bacigalupo, Giuseppe Milone, Alessandra Cupri, et al.
Blood Neoplasia|April 6, 2026
Late outcomes after posttransplant cyclophosphamide-based GVHD prophylaxis in patients with AML: an ALWP-EBMT studyEduardo Rodríguez-Arbolí, Allain-Thibeault Ferhat, Anna Maria Raiola, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|November 5, 2025
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMTVanderson Rocha, Myriam Labopin, Anna Maria Raiola, et al.
Bone Marrow Transplantation|May 13, 2022
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMTIvetta Danylesko, Christophe Peczynski, Myriam Labopin, et al.
Haematologica|July 5, 2006
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantationAlessandra Larocca, Giovanna Piaggio, Marina Podestà, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)Corrado Girmenia, Giovanni Barosi, Alfonso Piciocchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2018
Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission TomographyCarlo Marani, Anna Maria Raiola, Silvia Morbelli, et al.
Bone Marrow Transplantation|July 3, 2024
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)Gesine Bug, Myriam Labopin, Alexander Kulagin, et al.
American Journal of Hematology|March 4, 2026
Cryopreservation of Hemopoietic Cells for Allotransplant: Altered Immune Cell Subsets and Clinical ImplicationsAnna Maria Raiola, Paola Contini, Massimiliano Gambella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised PatientsMalgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, et al.
Haematologica|October 4, 2017
Steroid treatment of acute graft-<i>versus</i>-host disease grade I: a randomized trialAndrea Bacigalupo, Giuseppe Milone, Alessandra Cupri, et al.
Blood Neoplasia|April 6, 2026
Late outcomes after posttransplant cyclophosphamide-based GVHD prophylaxis in patients with AML: an ALWP-EBMT studyEduardo Rodríguez-Arbolí, Allain-Thibeault Ferhat, Anna Maria Raiola, et al.
Pageof 9